(Q45259943)

English

Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis

scientific article published in April 2005

In more languages
default values for all languages
No label defined

No description defined

Statements

Safety and tolerability of denufosol tetrasodium inhalation solution, a novel P2Y2 receptor agonist: results of a phase 1/phase 2 multicenter study in mild to moderate cystic fibrosis (English)
George Retsch-Bogart
Cystic Fibrosis Foundation Therapeutics Development Network

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit